Literature DB >> 11726804

Photic regulation of melatonin in rat retina and the role of proteasomal proteolysis.

C Fukuhara1, J C Dirden, G Tosini.   

Abstract

Several investigations have shown that illumination at night reduces melatonin level in the mammalian pineal, but the effect of night illumination on the retina is not known. In this study retinas were cultured in a flow-through apparatus and then were exposed to light at ZT 18. Light exposure reduced melatonin levels to the daytime level within 30 min. The reduction of melatonin levels was due to a rapid decrease in the activity of the enzyme AA-NAT; AA-NAT mRNA levels were not affected by illumination. Pre-incubation with lactacystin (25 microM) prevented light-induced reduction of AA-NAT activity and melatonin levels. These results demonstrate that melatonin levels in the mammalian retina are affected by light exposure at night, via proteosomal proteolysis of AA-NAT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11726804     DOI: 10.1097/00001756-200112040-00046

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  10 in total

1.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

2.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

Authors:  Margarita L Dubocovich; Philippe Delagrange; Diana N Krause; David Sugden; Daniel P Cardinali; James Olcese
Journal:  Pharmacol Rev       Date:  2010-07-06       Impact factor: 25.468

3.  Carbamate Insecticides Target Human Melatonin Receptors.

Authors:  Marina Popovska-Gorevski; Margarita L Dubocovich; Rajendram V Rajnarayanan
Journal:  Chem Res Toxicol       Date:  2017-01-11       Impact factor: 3.739

Review 4.  Melatonin: an underappreciated player in retinal physiology and pathophysiology.

Authors:  Gianluca Tosini; Kenkichi Baba; Christopher K Hwang; P Michael Iuvone
Journal:  Exp Eye Res       Date:  2012-08-31       Impact factor: 3.467

5.  Melatonin modulates visual function and cell viability in the mouse retina via the MT1 melatonin receptor.

Authors:  Kenkichi Baba; Nikita Pozdeyev; Francesca Mazzoni; Susana Contreras-Alcantara; Cuimei Liu; Manami Kasamatsu; Theresa Martinez-Merlos; Enrica Strettoi; P Michael Iuvone; Gianluca Tosini
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-14       Impact factor: 11.205

Review 6.  N-acetylserotonin: neuroprotection, neurogenesis, and the sleepy brain.

Authors:  Gianluca Tosini; Keqiang Ye; P Michael Iuvone
Journal:  Neuroscientist       Date:  2012-05-14       Impact factor: 7.519

7.  Cone Viability Is Affected by Disruption of Melatonin Receptors Signaling.

Authors:  Coralie Gianesini; Susumu Hiragaki; Virginie Laurent; David Hicks; Gianluca Tosini
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-01-01       Impact factor: 4.799

Review 8.  Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases.

Authors:  Marcos L Aranda; María Florencia González Fleitas; Hernán Dieguez; Agustina Iaquinandi; Pablo H Sande; Damián Dorfman; Ruth E Rosenstein
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

9.  Melatonin receptor heterodimerization in a photoreceptor-like cell line endogenously expressing melatonin receptors.

Authors:  Aída Sánchez-Bretaño; Ting-Chung Suen; Kenkichi Baba; Jason DeBruyne; Gianluca Tosini
Journal:  Mol Vis       Date:  2019-12-02       Impact factor: 2.367

Review 10.  Ocular Clocks: Adapting Mechanisms for Eye Functions and Health.

Authors:  Marie-Paule Felder-Schmittbuhl; Ethan D Buhr; Ouria Dkhissi-Benyahya; David Hicks; Stuart N Peirson; Christophe P Ribelayga; Cristina Sandu; Rainer Spessert; Gianluca Tosini
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-10-01       Impact factor: 4.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.